CD8A and lung cancer: Because IL-15 inhibits tumor growth by activating NK cells and CD8+ T cells, intravenous administration of ALT-803 significantly increased NK cell numbers and had a minor effect on CD8+ T-cell expansion in patients with lung cancer [94].